Drs. Devries and Whitley discuss the signs and risk factors of meibomian gland dysfunction (MGD) and the methods that can be used to assess the structure and function of the glands. You will learn about the importance of daily lid hygiene and what treatment options are currently available for patients with MGD.
This activity is supported by unrestricted educational grants from Alcon, Bausch + Lomb, Johnson & Johnson Vision, RVL, Sight Sciences, Tarsus, Théa Pharma, and Trukera Medical.
Upon completion of this activity, the participant should be able to:
Sponsored by 
Evolve Medical Education, LLC is a COPE-accredited administrator.
This activity, COPE Activity Number 125676, is accredited by COPE for continuing education for optometrists. This course is approved for 0.25 hours of CE.
Course #: 83654-TD
Activity #: 125676
COPE advises optometrists to contact the State or Provincial Board where they are licensed for verification of what is acceptable for license renewal.
In order to obtain credit, proceed through the program, complete the post-test, evaluation and submit for credit.
Douglas K. Devries, OD
Co-Founder and Managing Partner
Eye Care Associates of Nevada
Sparks, NV
Walter O. Whitley, OD, MBA, FAAO
Virginia Eye Consultants
EyeCare Partners, LLC
Norfolk, VA
DISCLOSURE POLICY
It is the policy of Evolve that faculty and other individuals who are in the position to control the content of this activity disclose any real or apparent financial relationships relating to the topics of this educational activity. Evolve has full policies in place that will identify and mitigate all financial relationships prior to this educational activity.
The following faculty/staff members have the following financial relationships with ineligible companies.
Douglas K. Devries, OD, has had a financial relationship or affiliation with the following ineligible companies in the form of Consultant: Alcon, Allergan, Asecula, Avellino, Azura Ophthalmics, Bausch + Lomb, BioTissue, Bruder Healthcare, Dompé, Johnson & Johnson Vision, Kala Pharmaceuticals, Lumenis, Novartis, OCuSOFT, Ocuphire Pharma, Oyster Point Pharma, Quidel, RVL, ScienceBased Health, Sight Sciences, Sun Pharma, Tarsus Pharmaceuticals, Théa Pharma, Trukera Medical, Verséa Health, and Visus. Speaker’s Bureau: Alcon, Bausch + Lomb, BioTissue, Dompé, Johnson & Johnson Vision, Kala Pharmaceuticals, Lumenis, Oyster Point Pharma, RVL, ScienceBased Health, Sight Sciences, and Sun Pharma. Stock/Shareholder: Ophthalmic Resources.
Walter O. Whitley, OD, MBA, FAAO, has had a financial agreement or affiliation with the following ineligible companies in the form of Consultant: Alcon, Allergan, Eyenovia, Heru, Iveric Bio, MediPrint Ophthalmics, Regener-Eyes, RVL Pharmaceuticals, Santen, and Thea Pharma. Advisory Board: Aerie Pharmaceuticals, Alcon, Allergan, Bausch + Lomb, Bruder, I-MED Pharma, Kala Pharmaceuticals, Oyster Point Pharma, RVL Pharmaceuticals, Santen, Science Based Health, Sun Pharmaceutical Industries, Tarsus, and Visus. Grant/Research Support: Heru. Speaker’s Bureau: Aerie Pharmaceuticals, Alcon, Allergan, Bausch + Lomb, Kala Pharmaceuticals, and Oyster Point Pharma. Editor: CollaborativeEye, Dry Eye Coach, and Review of Optometry. Co-Founder: New Sight Capital.
The Evolve staff, planners and peer reviewer have no financial relationships with ineligible companies.
OFF-LABEL STATEMENT
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The opinions expressed in the educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
DISCLAIMER
The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Evolve, The Fundingsland Group, Alcon, Bausch + Lomb, Johnson & Johnson Vision, RVL, Sight Sciences, Tarsus, Théa Pharma, or Trukera Medical.
This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.
Release Date:
Expiration Date:
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
John W. Kitchens, MD
Sara LeMay, OD
Sustaining Vision: Empowering Optometry for Tomorrow’s Retinal Care
1.00 creditArshad M. Khanani MD, MA, FASRS
Veeral Sheth, MD, MBA, FASRS, FACS
Lejla Vajzovic, MD, FASRS
Sunir J. Garg, MD, FACS, FASRS
Charles C. Wykoff, MD, PhD, FACS
Mark T. Dunbar, OD, FAAO
David Eichenbaum, MD
